In furtherance to intimation dated 28th January 2025 under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘SEBI Listing Regulations’), Cipla has informed that the Board of Directors of the Company at its meeting held on 28th January 2025 has approved the elevation of Achin Gupta, Chief Executive Officer - One India Business (SMP) as the Global Chief Operating Officer (GCOO) of the Company. Details required under the SEBI Listing Regulations read with the SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November 2024 is provided in Annexure A to this intimation. The meeting of the Board of Directors commenced at 11:00 am (IST) and concluded at 2:15 pm (IST).
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1625.90 |
| Dr. Reddys Lab | 1307.20 |
| Cipla | 1290.65 |
| Zydus Lifesciences | 923.30 |
| Lupin | 2306.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: